John L. Brottem - Mar 20, 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
General Counsel
Signature
John L Brottem
Stock symbol
OM
Transactions as of
Mar 20, 2023
Transactions value $
-$72,572
Form type
4
Date filed
3/21/2023, 04:30 PM
Previous filing
Feb 16, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $13.4K +1.42K +2.2% $9.48 65.7K Mar 20, 2023 Direct F1
transaction OM Common Stock Sale -$29.5K -1.42K -2.15% $20.82 64.3K Mar 20, 2023 Direct F2
transaction OM Common Stock Sale -$56.5K -2.72K -4.22% $20.82 61.6K Mar 20, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.42K -6.25% $0.00 21.2K Mar 20, 2023 Common Stock 1.42K $9.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.